URSODESOXYCHOLIC ACID MYLAN 250 mg tab pellic,,,URSODESOXYCHOLIC ACID 250 mg tab (URSODESOXYCHOLIC ACID MYLAN)

 DELURSAN 250 mg tab pellic

pharmacotherapeutic classification:

Gastro-Entero-Hepatology : Primary biliary cirrhosis ( Ursodeoxycholic acid )
Metabolism - Diabetes - Nutrition - Mucoviscidosis : Liver damage: ursodeoxycholic acid ( Cholelithiasis: bile acid )

ATC classification:

DIGESTIVE TRACT AND METABOLISM : HEPATIC AND BILIARY THERAPY - BILIARY THERAPY : BILE ACIDS AND DERIVATIVES ( URSODESOXYCHOLIC ACID )

Substance
ursodeoxycholic acid

Excipients:

corn starch , sodium lauryl sulfate , povidone , colloidal anhydrous silica , magnesium stearate

colorant (film coating):  titanium dioxide

film coating:  hypromellose , propylene glycol

Excipients with known effect :

NTE without threshold dose:  anhydrous glucose

Presentation

URSODESOXYCHOLIC ACID MYLAN 250 mg Cpr pell Plq/20

Cip: 3400922333984

Storage conditions: Before opening: for 36 months

List 1

Approved for Communities

Refund: 65%